AP636A - Zwitterionic forms of trovafloxacin. - Google Patents

Zwitterionic forms of trovafloxacin. Download PDF

Info

Publication number
AP636A
AP636A APAP/P/1996/000853A AP9600853A AP636A AP 636 A AP636 A AP 636A AP 9600853 A AP9600853 A AP 9600853A AP 636 A AP636 A AP 636A
Authority
AP
ARIPO
Prior art keywords
compound
polymorph
hygroscopic
treating
pentahydrate
Prior art date
Application number
APAP/P/1996/000853A
Other languages
English (en)
Other versions
AP9600853A0 (en
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9600853A0 publication Critical patent/AP9600853A0/xx
Application granted granted Critical
Publication of AP636A publication Critical patent/AP636A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
APAP/P/1996/000853A 1995-08-29 1996-08-29 Zwitterionic forms of trovafloxacin. AP636A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (2)

Publication Number Publication Date
AP9600853A0 AP9600853A0 (en) 1996-10-31
AP636A true AP636A (en) 1998-04-09

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000853A AP636A (en) 1995-08-29 1996-08-29 Zwitterionic forms of trovafloxacin.

Country Status (30)

Country Link
EP (1) EP0850060A1 (ru)
JP (1) JP3188476B2 (ru)
KR (1) KR100343909B1 (ru)
CN (1) CN1190889A (ru)
AP (1) AP636A (ru)
AR (1) AR003985A1 (ru)
AU (1) AU704115B2 (ru)
BR (1) BR9609998A (ru)
CA (1) CA2229786C (ru)
CO (1) CO4480739A1 (ru)
CZ (1) CZ56698A3 (ru)
DZ (1) DZ2087A1 (ru)
GT (1) GT199600072A (ru)
HR (1) HRP960395B1 (ru)
HU (1) HUP9900170A3 (ru)
IL (1) IL122651A (ru)
MA (1) MA23966A1 (ru)
MY (1) MY113874A (ru)
NO (1) NO309814B1 (ru)
NZ (1) NZ312199A (ru)
OA (1) OA10669A (ru)
PE (1) PE12598A1 (ru)
PL (1) PL325170A1 (ru)
RU (1) RU2144921C1 (ru)
SK (1) SK23898A3 (ru)
TN (1) TNSN96109A1 (ru)
TR (1) TR199800339T1 (ru)
WO (1) WO1997007800A1 (ru)
YU (1) YU48396A (ru)
ZA (1) ZA967282B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5229396A (en) * 1989-08-16 1993-07-20 Pfizer Inc. Anti-bacterial azabicyclo quinolone carboxylic acids

Also Published As

Publication number Publication date
TR199800339T1 (xx) 1998-06-22
KR19990044232A (ko) 1999-06-25
AU704115B2 (en) 1999-04-15
MX9801664A (es) 1998-08-30
JPH10511692A (ja) 1998-11-10
IL122651A0 (en) 1998-08-16
MY113874A (en) 2002-06-29
HUP9900170A2 (hu) 1999-05-28
EP0850060A1 (en) 1998-07-01
NO980862D0 (no) 1998-02-27
CA2229786A1 (en) 1997-03-06
CN1190889A (zh) 1998-08-19
CZ56698A3 (cs) 1999-02-17
IL122651A (en) 2000-02-17
HRP960395A2 (en) 1998-06-30
ZA967282B (en) 1998-03-02
YU48396A (sh) 1998-12-23
CO4480739A1 (es) 1997-07-09
JP3188476B2 (ja) 2001-07-16
GT199600072A (es) 1998-02-14
BR9609998A (pt) 1999-07-06
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
AU6367696A (en) 1997-03-19
SK23898A3 (en) 1999-05-07
AR003985A1 (es) 1998-09-30
RU2144921C1 (ru) 2000-01-27
KR100343909B1 (ko) 2003-04-10
WO1997007800A1 (en) 1997-03-06
DZ2087A1 (fr) 2002-07-22
AP9600853A0 (en) 1996-10-31
HUP9900170A3 (en) 1999-11-29
TNSN96109A1 (fr) 2005-03-15
OA10669A (en) 2000-11-06
NO980862L (no) 1998-02-27
MA23966A1 (fr) 1997-04-01
NZ312199A (en) 1999-06-29
PL325170A1 (en) 1998-07-06
NO309814B1 (no) 2001-04-02
PE12598A1 (es) 1998-03-20

Similar Documents

Publication Publication Date Title
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
EP0579681B1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
AP636A (en) Zwitterionic forms of trovafloxacin.
US6066647A (en) Zwitterionic forms of trovafloxacin
EP0847400B1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis
AP788A (en) Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
CA2258960C (en) A process for preparing naphthyridones and intermediates
MXPA98001665A (en) Polymorphoses of profarmaco of 6-n- (l-ala-l-ala) -trovafloxacin, procedure for its preparation and use of mis
EP1743893A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol